drugset / Trial / NCT00076856
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate improvement in overall survival for the combination of whole brain radiation therapy (WBRT) plus temozolomide (TMZ) versus WBRT alone. Secondary objective is to demonstrate an improvement in the time to radiological CNS progression with the addition of TMZ to WBRT.
Timeline
- Start
- 2004-03-31
- Primary completion
- 2006-03-31
- Completion
- 2006-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 75 mg/m2 | — |